Origin Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Origin Biosciences's estimated annual revenue is currently $1.4M per year.
- Origin Biosciences's estimated revenue per employee is $155,000
Employee Data
- Origin Biosciences has 9 Employees.
- Origin Biosciences grew their employee count by -18% last year.
Origin Biosciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Senior Medical Science Liaison (neurology and rare genetic disease) | Reveal Email/Phone |
Origin Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.3M | 21 | 31% | N/A | N/A |
What Is Origin Biosciences?
Origin Biosciences, a subsidiary of BridgeBio Pharma, is a biotechnology company focused treatment for Molybdenum Cofactor Deficiency (MoCD). Origin is led by a team of veteran biotechnology executives. Together with patients and physicians, the company aims to bring a safe, effective treatment for MoCD to market as quickly as possible.
keywords:N/A
N/A
Total Funding
9
Number of Employees
$1.4M
Revenue (est)
-18%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Palo Alto
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 9 | 50% | N/A |
#2 | $0.7M | 9 | -18% | N/A |
#3 | $0.9M | 9 | -10% | N/A |
#4 | $0.7M | 9 | -10% | N/A |
#5 | N/A | 9 | 29% | N/A |